{"public_id":"co_58358f8035359b7f457d440a7f1b5411","status":"active","merged_into_public_id":null,"resolved_public_id":"co_58358f8035359b7f457d440a7f1b5411","name":"glucocorticoid treatment","description":"Use of glucocorticoid medications, identified as a major trigger for hyperinfection.","aliases":[],"types":["treatment"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":30013731,"title":"Strongyloides stercoralis in the Immunocompromised Population","citation_count":846,"url":"https://sah.borca.ai/papers/30013731"}],"claims":[{"public_id":"cl_581f958b198ce63cddda220e80a65630","text":"Glucocorticoid treatment and human T-lymphotropic virus type 1 infection are the conditions most specifically associated with triggering hyperinfection.","corpus_id":30013731,"url":"https://sah.borca.ai/claims/cl_581f958b198ce63cddda220e80a65630"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_58358f8035359b7f457d440a7f1b5411","url":"https://sah.borca.ai/concepts/co_58358f8035359b7f457d440a7f1b5411"}